TTK Healthcare Limited
National Stock Exchange of IndiaTotal Valuation
TTK Healthcare Limited carries a market capitalization of 12.99B, placing it among publicly traded companies globally. Its enterprise value stands at 18.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 12.99B |
| Enterprise Value | 18.05B |
Valuation Ratios
TTK Healthcare Limited trades at a trailing price-to-earnings ratio of 28.62.
| PE Ratio | 28.62 |
| PS Ratio | 2.20 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, TTK Healthcare Limited trades at an EV/EBITDA multiple of 81.59 and an EV/FCF ratio of 753.47. The EV/Sales ratio of 2.20 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 81.59 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.20 |
| EV / EBITDA | 81.59 |
| EV / EBIT | 81.59 |
| EV / FCF | 753.47 |
Financial Position
TTK Healthcare Limited maintains a current ratio of 10.40, meaning it holds 10.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.27, indicating elevated leverage, while an interest coverage ratio of 6.84 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 10.40 |
| Quick Ratio | 8.25 |
| Debt / Equity | 5.27 |
| Debt / EBITDA | N/A |
| Interest Coverage | 6.84 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 198.54 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, TTK Healthcare Limited has paid 221.10M in income taxes, reflecting an effective tax rate of 25.95.
| Income Tax | 221.10M |
| Effective Tax Rate | 25.95 |
Stock Price Statistics
TTK Healthcare Limited's stock has declined approximately -29.28753% over the past 52 weeks. The 50-day moving average sits at 907.35, while the 200-day moving average is 979.86.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29.28753% |
| 50-Day Moving Average | 907.35 |
| 200-Day Moving Average | 979.86 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, TTK Healthcare Limited generated 8.20B in revenue and converted that into 630.81M in net income, yielding earnings per share of 44.64. EBITDA reached 221.27M, while operating income came in at 221.27M.
| Revenue | 8.20B |
| Gross Profit | 4.43B |
| Operating Income | 221.27M |
| Pretax Income | 851.91M |
| Net Income | 630.81M |
| EBITDA | 221.27M |
| EBIT | 221.27M |
| Earnings Per Share (EPS) | 44.64 |
Margins
TTK Healthcare Limited operates with a gross margin of 54.00, reflecting its pricing power and cost economics. The operating margin of 2.70 and net profit margin of 7.69 provide insight into operational efficiency.
| Gross Margin | 54.00 |
| Operating Margin | 2.70 |
| Pretax Margin | 10.39 |
| Profit Margin | 7.69 |
| EBITDA Margin | 2.70 |
Scores
TTK Healthcare Limited posts an Altman Z-Score of 15.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 15.00 |